Top Story

Maintenance pazopanib extended PFS, not OS in ovarian cancer

October 24, 2014

Maintenance therapy with pazopanib extended PFS by about 45% among women with ovarian cancer whose disease did not progress during first-line chemotherapy, according to results of a phase 3 study.

However, the maintenance regimen did not appear to confer an OS benefit.

figure Meeting News CoverageVideo

Michael H. Davidson, MD, discusses PCSK9 as a target of therapy

October 24, 2014
BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, outlines a session he participated in at the Cardiometabolic Health…
figure Meeting News CoverageVideo

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed primarily at diabetes or metabolic disease poses…
figure Meeting News Coverage

Efficacy, safety of aspirin for treatment of patients with diabetes, CAD unclear

October 24, 2014
BOSTON — The benefits of using aspirin, alone or with a platelet inhibitor, for the treatment of patients with diabetes at high-risk for CVD are still unclear…
More News Headlines »
CNE
figure

Journal of Psychosocial Nursing and Mental Health Services Oct 2014 CNE Activity

This activity is co-provided by Villanova University College of Nursing and SLACK Incorporated.

Topics include simulation in psychiatric nursing education.
More »
Short Subjects

A Rare Association of Intravitreal Bevacizumab Injection With Double Ridge Formation in Retinopathy of Prematurity

Journal of Pediatric Ophthalmology and Strabismus, Volume -2147483648
Online Only, October 8, 2014
A second anterior ridge formed 8 weeks after therapy in a case of zone II, stage 3 retinopathy of prematurity, which…
More »
Meeting News Coverage Video
figure

Michael H. Davidson, MD, discusses PCSK9 as a target of therapy

October 24, 2014
BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, outlines a session he…
More »